The Significance of the Homozygous CYP2A6 Deletion on Nicotine Metabolism: A New Genotyping Method of CYP2A6 Using a Single PCR–RFLP
- 19 August 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 262 (1), 146-151
- https://doi.org/10.1006/bbrc.1999.1182
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomesArchives of Toxicology, 1999
- A Study for the Proper Application of Urinary Naphthols, New Biomarkers for Airborne Polycyclic Aromatic HydrocarbonsArchives of Environmental Contamination and Toxicology, 1999
- A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3 -pyridyl)thiazolidin-4-one hydrochloride (SM-12502)Pharmacogenetics, 1998
- Nomenclature for human CYP2D6 allelesPharmacogenetics, 1996
- Habitual and genetic factors that affect urinary background levels of biomarkers for organic solvent exposureArchives of Environmental Contamination and Toxicology, 1996
- Effects of ALDH2, CYP1A1, and CYP2E1 Genetic Polymorphisms and Smoking and Drinking Habits on Toluene Metabolism in HumansToxicology and Applied Pharmacology, 1995
- A tobacco smoke-derived nitrosamine, 4-(methytnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytocbrome P450s including the polymorphic human cytochrome P4502D6Carcinogenesis: Integrative Cancer Research, 1991
- Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1.Proceedings of the National Academy of Sciences, 1990
- The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomesBiochemistry, 1990
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979